References
- Marchand T, Revest M, Tattevin P, . Early cryptococcal meninigitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia. Leuk Lymphoma 2013;54;640–642.
- Thursky KA, Worth LJ, Seymour JF, . Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab. Br J Haematol 2006;132:3–12.
- Bassetti M, Repetto E, Mikulska M, . Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature. J Chemother 2009;21:211–214.
- Kontoyiannis DP, Peitsch WK, Reddy BT, . Crytococcosis in patients with cancer. Clin Infect Dis 2001;32:e145–e150.
- Hirai Y, Ainoda Y, Shoji T, . Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review. Mycopathologica 2011;172:227–232.
- Ingram PR, Howman R, Leahy MF, . Cryptococcal immune reconstitution inflammatory syndrome following alemtuzumab therapy. Clin Infect Dis 2007;44:e115–e117.
- Chen S, Sorrell T, Nimmo G, . Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000;31: 499–508.
- Perfect JR, Dismukes WE, Dromer F, . Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010:50: 291–322.
- MacDougall L, Fyfe M, Romney M, . Risk factors for Cryptococcus gattii infection, British Columbia. Emerg Infect Dis 2011;17:193–199.
- Chen SCA, Slavin MA, Heath CH, . Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis 2012;55:789–798.
- Safdieh JE, Mead PA, Sepkowitz KA, . Bacterial and fungal meningitis in patients with cancer. Neurology 2008;709:943–947.
- Dewar GJ, Kelly JK. Cryptococcosis gatti: an emerging cause of pulmonary nodules. Can Respir J 2008;15:153–157.
- Wong M, Loong F, Khong PL, . Mediastinal cryptococcosis masquerading as therapy-refractory lymphoma. Ann Haematol 2011;90:601–602.
- Dromer F, Mathoulin-Pelissier S, Launay O, . French Cryptococcosis Study Group. Determinants of disease presentation and outcome during cryptococcosis:the CryptoA/D Study. PLoS Med 2007;4:e21.